Cerus Corporation's PIPE - II Round

Cerus Corporation raised a round of funding on May 16, 2018. Investors include Biomedical Advanced Research and Development Authority.

Cerus Corporation is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System is designed to inactivate blood-borne patho…

Articles about Cerus Corporation's PIPE - II Round: